Trials / Completed
CompletedNCT01302132
Mass Balance Study of ASP1941
An Open Label Study to Evaluate the Pharmacokinetics of ASP1941 After a Single Oral Dose of 14C-labeled ASP1941 in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study investigates the pharmacokinetics, in particular the routes and extent of metabolism and excretion, of ASP1941 after a single oral dose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASP1941 | Oral solution |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2008-10-01
- Completion
- 2008-10-01
- First posted
- 2011-02-23
- Last updated
- 2011-02-23
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01302132. Inclusion in this directory is not an endorsement.